NMTC NASDAQ
NeuroOne Medical Technologies Corporation
1W: -13.5%
1M: -31.1%
3M: -62.8%
YTD: +34.9%
1Y: +29.3%
3Y: +18.7%
5Y: -72.5%
$1.12
+0.13 (+13.69%)
Weekly Expected Move ±13.9%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-10-14
Earliest Filing
2025-04-07
Latest Filing
partner: 3
investor: 1
Counterparties (Filed by NMTC)
4 relationshipsCompanies named in NMTC's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ladenburg Thalmann & Co. Inc. | — | partner | Underwriter for the issuance and sale of 16,000,000 shares of common stock. | 2025-04-07 | View |
| Zimmer, Inc. | ZBH | partner | NeuroOne granted Zimmer exclusive rights to distribute NeuroOne's OneRF Ablation System. | 2024-10-31 | View |
| The Benchmark Company, LLC | — | partner | Entered into an underwriting agreement for the issuance and sale of common stock. | 2023-07-27 | View |
| Craig-Hallum Capital Group LLC | — | investor | Underwriter for the issuance and sale of 3,750,000 shares of common stock. | 2021-10-14 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-27 | Other Events; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-06-12 | Other Events; Exhibits | View | |
| 2026-05-22 | Financial Restatement; Regulation FD; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-05-04 | Other Events | View | |
| 2026-04-30 | Officer/Director Change; Exhibits | View | |
| 2026-04-14 | Bylaws Amendment; Exhibits | View | |
| 2026-04-03 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-02-25 | Other Events | View | |
| 2026-02-17 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-22 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-12-17 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-05 | Notice of Delisting or Transfer | View | |
| 2025-10-06 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-18 | Other Events | View | |
| 2025-08-15 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-05-09 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR